Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Pediatric Vaccines
Researchers from Oxford University, Department of Paediatrics report recent findings in pediatric vaccines
April 29th, 2009
New investigation results, 'Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine,' are detailed in a study published in Immunology. According to recent research from Oxford, the United Kingdom, "The induction of persistent protective levels of pathogen-specific antibody is an important goal of immunization against childhood infections. However, antibody persistence is poor after immunization in infancy versus later in life." "Serogroup C meningococci (MenC) are an important cause of bacteraemia and meningitis in children. The use of protein-polysaccharide conjugate...
Source: Vaccine Weekly (2009-04-29)
|
